A Randomized Multicenter Double Masked Parallel-Group Study Assessing the Safety and Efficacy of Loteprednol Etabonate Ophthalmic Gel 0.5% versus Prednisolone Acetate Ophthalmic Suspension 1% for the Treatment of Intraocular Inflammation Following Su
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to evaluate the safety and effectiveness of Loteprednol Etabonate Ophthalmic Gel, 0.5% (LE ophthalmic gel) taken for 29 days compared to Prednisolone Acetate Ophthalmic Suspension, USP, 1% (Pred Forte) taken for 29 days, for t
Description
The purpose of this study is to evaluate the safety and effectiveness of Loteprednol Etabonate Ophthalmic Gel, 0.5% (LE ophthalmic gel) taken for 29 days compared to Prednisolone Acetate Ophthalmic Suspension, USP, 1% (Pred Forte) taken for 29 days, for t
Details
| Condition | Cataracts |
|---|---|
| Age | 11years or below |
| Clinical Study Identifier | TX2940 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.